Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function

Genes and Development

Volumn 8, Issue 24, 1994, Pages

  Guan, Kun Liang ^a   Jenkins, Christopher W ^c   Li, Yan ^c   Nichols, Michael A ^c   Wu, Xiaoyu ^a   O'Keefe, Christine L ^b   Matera, A Gregory ^b   Xiong, Yue ^c  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

CDK4 and CDK6 interacting proteins; Cell cycle; Cyclin dependent kinase inhibitors

Indexed keywords

CELL PROTEIN; COMPLEMENTARY DNA; CYCLIN DEPENDENT KINASE; ENZYME INHIBITOR; GLUTATHIONE TRANSFERASE; HISTIDINE; HYBRID PROTEIN; RETINOBLASTOMA PROTEIN;

ARTICLE; CELL CYCLE; CELL GROWTH; COMPLEX FORMATION; DNA SEQUENCE; ENZYME INHIBITION; GROWTH INHIBITION; HUMAN; HUMAN CELL; KERATINOCYTE; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

AMINO ACID SEQUENCE; BASE SEQUENCE; CARRIER PROTEINS; CELL DIVISION; CELL LINE; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 1; CLONING, MOLECULAR; COMPARATIVE STUDY; DNA PRIMERS; FEMALE; FUNGAL PROTEINS; HUMAN; KERATINOCYTES; MOLECULAR SEQUENCE DATA; PLACENTA; PREGNANCY; PROTEIN-SERINE-THREONINE KINASES; RETINOBLASTOMA PROTEIN; RNA-BINDING PROTEINS; SACCHAROMYCES CEREVISIAE; SEQUENCE HOMOLOGY, AMINO ACID; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0028582034     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.8.24.2939     Document Type: Article

References (64)

1. Andrews, B.J. and I. Herskowitz. 1989. The yeast SWI4 protein contains a motif present in developmental regulators and is part of a complex involved in cell-cycle dependent transcription. Nature 342: 830-833.
2. Bale, S.J., N.C. Dracopoli, M.A. Tucker, W.H. Clark, M.C. Fraser, B.Z. Stranger, P. Green, H. Donnis-Keller, D.E. Housman, and M.H. Greene. 1989. Mapping the gene for hereditary cutaneous malignant melanoma-dysplastic nevus to chromosome 1p. N. Engl. J. Med. 320: 1367-1372.
3. Ballard, S.G. and D.C. Ward. 1993. Fluorescence in situ hybridization using digital imaging microscopy. J. Histochem. Cytochem. 41: 1755-1759.
4. Bardi, G., B. Johansson, N. Pandis, N. Mandahl, E. Bak-Jensen, A. Andren-Sandberg, F. Mitelman, and S. Heim. 1993. Karyotypic abnormalities in tumors of the pancreas. Br. J. Cancer 67: 1106-1112.
5. Bartel, P.L., C.-T. Chien, R. Sternglanz, and S. Fields. 1993. Using the two hybrid system to detect protein-protein interactions. In Cellular interactions in development: A practical approach (ed. D.A. Hartley), pp. 153-179. Oxford University Press, Oxford, UK.
6. Bieche, I., M.-H. Champeme, and R. Lidereau. 1994. A tumor suppressor gene on chromosome 1p32-pter controls the amplification of MYC family genes in breast cancer. Cancer Res. 54: 4274-4276.
7. Bierkamp, C. and J.A. Campos-Ortega. 1993. A zebrafish homologue of the Drosophila neurogenic gene Notch and its pattern of transcription during early embryogenesis. Mech. Dev. 43: 87-100.
8. Boukamp, P., R.T. Petrussevska, D. Breitkreutz, J. Hornung, A. Markham, and N.E. Fusenig. 1988. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell Biol. 106: 761-771.
9. Breeden, L. and K. Nasmyth. 1987. Similarity between cell-cycle genes of budding yeast and fission yeast and the Notch gene of Drosophila. Nature 329: 651-654.
10. Caldas, C., S.A. Hahn, L.T. da Costa, M.S. Redston, M. Schutte, A.B. Seymour, C.L. Weinstein, R.H. Hruban, C.J. Yeo, and S.E. Kern. 1994. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nature Genet. 8: 27-32.
11. Coche, T., D. Prozzi, M. Legrain, F. Hilger, and J. Vandenhaute. 1990. Nucleotide sequence of the PHO81 gene involved in the regulation of the repressible acid phosphatase gene in Saccharomyces cerevisiae. Nucleic Acids Res. 18: 2176.
12. Coffman, C., W. Harris, and C. Kintner. 1990. Xotch, the Xenopus homolog of Drosophila notch. Science 249: 1438-1441.
13. Dowdy, S.F., P.W. Hinds, K. Louie, S.I. Reed, A. Arnold, and R.A. Weinberg. 1993. Physical interaction of the retinoblastoma protein with human D cyclins. Cell 73: 499-511.
14. Draetta, G. 1990. Cell cycle control in eukaryotes: Molecular mechanisms of cdc2 activation. Trends. Biol. Sci. 15: 378-383.
15. Dulic, V., W.K. Kaufmann, S.J. Wilson, T.D. Tlsty, E. Lees, J.W. Harper, S.J. Elledge, and S.I. Reed. 1994. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 76: 1013-1023.
16. El-Deiry, W.S., T. Tokino, V.E. Velculescu, D.B. Levy, R. Parsons, D.M. Lin, W.E. Mercer, K.W.V. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825.
17. Ellisen, L.W., J. Bird, D.C. West, A.L. Soreng, T.C. Reynolds, S.D. Smith, and J. Sklar. 1991. TAN-1, the human homolog of the Drosophila Notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell 66: 649-661.
18. Ewen, M.E. 1994. The cell cycle and the retinoblastoma protein family. Cancer Metastasis Rev. 13: 45-66.
19. Ewen, M.E., H.K. Sluss, C.J. Sherr, H. Matsushime, J. Kato, and D.M. Livingston. 1993. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 73: 487-497.
20. Firpo, E.J., A. Koff, M.J. Solomon, and J.M. Roberts. 1994. Inactivation of a Cdk2 inhibitor during interleukin 2-induced proliferation of human T lymphocytes. Mol. Cell Biol. 14: 4889-4901.
21. Greenwald, I.S. and G.M. Rubin. 1992. Making a difference: The role of cell-cell interactions in establishing separate identities for equivalent cells. Cell 68: 271-281.
22. Gu, Y., C.W. Turck, and D.O. Morgan. 1993. Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature 366: 707-710.
23. Guan, K.L. and J.E. Dixon. 1991. Eukaryotic proteins expressed in Escherichia coli: An improved thrombin cleavage and purification procedure of fusion proteins with glutathione S-transferase. Anal. Biochem. 192: 262-267.
24. Hainsworth, P.J., K.L. Raphael, R.G. Stillwell, R.C. Bennett, and O.M. Garson. 1991. Cytogenetic features of twenty-six primary breast cancers. Cancer Genet. Cytogenet. 52: 205-218.
25. INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature 371: 257-261.
26. Harper, J.W., G.R. Adami, N. Wei, K. Keyomarsi, and S.J. Elledge. 1993. The p21 cdk-interacting protein cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805-816.
27. Hengst, L., V. Dulic, J.M. Slingerland, E. Lees, and S.I. Reed. 1994. A cell cycle-regulated inhibitor of cyclin-dependent kinases. Proc. Natl. Acad. Sci. 91: 5291-5295.
28. Hussussian, C.J., J.P. Struewing, A.M. Goldstein, P.A.T. Higgins, D.S. Ally, M.D. Sheahan, W.H. Clark, M.A. Tucker, and N.C. Dracopoli. 1994. Germline p16 mutations in familial melanoma. Nature Genet. 8: 15-21.
29. Inaba, T., H. Matsushime, M. Valentine, M.F. Roussel, C.J. Sherr, and A.T. Look. 1992. Genomic organization, chromosomal localization, and independent expression of human cyclin D genes. Genomics 13: 565-574.
30. Kamb, A., N.A. Gruis, J. Weaver-Feldhaus, Q. Liu, K. Harshman, S.V. Tavitgian, E. Stockert, R.S. Day, B.E. Johnson, and M.H. Skolnick. 1994a. A cell cycle regulator potentially involved in genesis of many tumor types. Science 264: 436-440.
31. Kamb, A., D. Shattuck-Eidens, R. Eeles, Q. Liu, N.A. Gruis, W. Ding, C. Hussey, T. Tran, Y. Miki, J. Weaver-Feldhaus, M. McClure, J.F. Aitken, D.E. Anderson, W. Bergman, R. Frants, D.E. Goldgar, A. Green, R. MacLennan, N.G. Martin, L.J. Meyer, P. Youl, J.J. Zone, M.H. Skolnick, and L.A. Cannon-Albright. 1994b. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nature Genet. 8: 22-26.
32. Kato, J-Y., H. Matsushime, S.W. Hiebert, M. Ewen, and C.J. Sherr. 1993. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes & Dev. 7: 331-342.
33. Li, Y., M.A. Nichols, J.W. Shay, and Y. Xiong. 1994. Transcriptional repression of the D-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product, pRb. Cancer Res. (in press).
34. Lichter, P., C.-J.C. Tang, K. Call, G. Hermanson, G.A. Evans, D. Housman, and D.C. Ward. 1990. High resolution mapping of human chromosome 11 by in situ hybridization with cosmid clones. Science 247: 64-69.
35. Lukas, J., H. Muller, J. Bartkova, D. Spitkovsky, A.A. Kjeruff, P. Jansen-Durr, M. Strauss, and J. Bartek. 1994. DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1. J. Cell Biol. 125: 625-638.
36. Matsushime, H., D.E. Quelle, S.A. Shurtleff, M. Shibuya, C.J. Sherr, and J.-Y. Kato. 1994. D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell Biol. 14: 2066-2076.
37. Meyerson, M. and E. Harlow, 1994. Identification of G1 kinase activity for cdk6, a novel cyclin D partner. Mol. Cell Biol. 14: 2077-2086.
38. Meyerson, M., G.H. Enders, C.-L. Wu, L.-K. Su, C. Gorka, C. Neilson, E. Harlow, and L.-H. Tsai. 1992. A family of human cdc2-related protein kinases. EMBO J. 11: 2909-2917.
39. Mori, T., K. Miura, T. Aoki, T. Nishihira, N. Shozo, and Y. Nakamura. 1994. Frequent somatic mutation of the MTS1/CDK4I (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. Cancer Res. 54: 3396-3397.
40. Nobori, T., K. Mlura, D.J. Wu, A. Lois, K. Takabayashi, and D.A. Carson. 1994. Deletion of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368: 753-756.
41. Noda, A., Y. Ning, S.F. Venable, O.M. Pereira-Smith, and J.R. Smith. 1994. Cloning of a senescent cell-derived inhibitor of DNA synthesis using an expression screen. Exp. Cell. Res. 211: 90-98.
42. Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes & Dev. 8: 9-22.
43. Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78: 59-66.
44. Schleiermacher, G., M. Peter, J. Michon, J.-P. Hugot, P. Vielh, J.-M. Zucker, H. Magdelenat, T. Gilles, and O. Delattre. 1994. Two distinct deleted regions on the short arm of chromosome I in neuroblastoma. Genes Chromosomes Cancer 10: 275-281.
45. Schneider, K.R., R.L. Smith, and E.K. O'Shea 1994. Phosphate-regulated inactivation of the kinase PHO80-PHO85 by CDK inhibitor PHO81. Science 266: 122-126.
46. Serrano, M., G.J. Hannon, and D. Beach. 1993. A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4. Nature 366: 704-707.
47. Sherr, C. 1993. Mammalian G1 cyclins. Cell 73: 1059-1065.
48. Shew, J.Y., B.T. Lin, P.L. Chen, B.Y. Tseng, T.L. Yang-Feng, and W.H. Lee. 1990. C-terminal truncation of the retinoblastoma gene product leads to functional inactivation. Proc. Natl. Acad. Sci. 87: 6-10.
49. Slingerland, J.M., L. Hengst, C.-H. Pan, D. Alexander, M.R. Stampfer, and S.I. Reed. 1994. A novel inhibitor of cyclin-Cdk activity detected in transforming growth factor β-arrested epithelial cells. Mol. Cell. Biol. 14: 3683-3694.
50. Sokova, O.I., O.P. Kirichenko, A.F. Mukeria, L.V. Demidov, A.N. Chebotarev, and B.P. Kopnin. 1992. Enhanced expression of 1p32 and 1q22 fragile sites in lymphocytes in cutaneous malignant melanomas. Cancer Genet. Cytogenet. 58: 24-28.
51. Spruck, C.H. III, M. Gonzalez-Zulueta, A. Shibata, A.R. Simoneau, M.-F. Lin, F. Gonzales, Y.C. Tsai, and P.A. Jones. 1994. p16 gene in uncultured tumors. Nature 370: 183-184.
52. Sreekantaiah, C., J.R. Davis, and A.A. Sandberg. 1993. Chromosomal abnormalities in leiomyosarcomas. Am. J. Pathol. 142: 293-305.
53. Studier, F.W., A.H. Rosenberg, J.J. Dunn, and J.W. Dubendorff. 1990. RNA polymerase to direct expression of cloned genes. Methods Enzymol. 185: 60-89.
54. Tam, S.W., A.M. Theodoras, J.W. Shay, G.F. Draetta, and M. Pagano. 1994. Differential expression and regulation of Cyclin D1 protein in normal and tumor human cells: association with Cdk4 is required for Cyclin D1 function in G1 progression. Oncogens 9: 2663-2674.
55. Toyoshima, H. and T. Hunter. 1994. p27, a novel inhibitor of G1 cyclin-Cdk proteins kinase activity, is related to p21. Cell 78: 67-74.
56. Wharton, K.A., K.M. Johansen, T. Xu, and S. Artavanis-Tsakonas. 1985. Nucleotide sequence from the neurogenic locus notch implies a gene product that shares homology with proteins containing EGF-like repeats. Cell 43: 567-581.
57. Won, K.A., Y. Xiong, D. Beach, and M.Z. Gilman. 1992. Growth-regulated expression of D-type cyclin genes in human diploid fibroblasts. Proc. Natl. Acad. Sci. 89: 9910-9914.
58. Xiong, Y., T. Connolly, B. Futcher, and D. Beach. 1991. Human D-type cyclin. Cell 65: 691-699.
59. Xiong, Y., H. Zhang, and D. Beach. 1992. D-type cyclins associated with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 71: 505-514.
60. Xiong, Y., G. Hannon, H. Zhang, D. Casso, R. Kobayashi, and D. Beach. 1993a. p21 is a universal inhibitor of the cyclin kinases. Nature 366: 701-704.
61. Xiong, Y., H. Zhang, and D. Beach. 1993b. Subunit rearrangement of cyclin-dependent kinases is associated with cellular transformation. Genes & Dev. 7: 1572-1583.
62. Zhang, H., Y. Xiong, and D. Beach. 1993. Proliferating cell nuclear antigen and p21 are components of multiple cell cycle kinase complexes. Mol. Biol. Cell 4: 897-906.
63. Zhang, H., G.J. Hannon, and D. Beach. 1994. p21-containing cyclin kinases exist in both active and inactive states. Genes & Dev. 8: 1750-1758.
64. Zhu, L., S. van den Heuvel, K. Helin, A. Fattaey, M. Ewen, D. Livingston, N. Dyson, and E. Harlow. 1993. Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. Genes & Dev. 7: 1111-1125.